387. This Month in MedTech: Q1 Earnings, M&A Momentum, and the Rise of Focused Strategics

In this episode of This Month in MedTech, Omar Khateeb speaks with Nicholas Talamantes, Sr. Director at Life Science Intelligence, about the market signals shaping MedTech right now.The discussion covers Q1 earnings from major strategics, the rise of focused growth platforms, Boston Scientific’s $1.5B bet on structural heart, and the latest M&A activity from J&J, Medtronic, ResMed, Roche, and Artivion.Omar and Nicholas also break down why focus is being rewarded in public markets, why large platforms are divesting non-core assets, and how commercial proof, option structures, and tuck-in acquisitions are shaping the next wave of MedTech deals.A must-listen for anyone tracking MedTech growth, healthcare M&A, cardiovascular innovation, AI diagnostics, surgical robotics, and the strategic decisions defining the next market cycle.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown00:00 Why Focused MedTech Companies Are Winning00:02 Intro + This Month in MedTech02:03 Q1 Earnings Overview and Market Trends03:54 AI Hype vs Healthcare Revenue Reality05:40 What Q1 Earnings Tell Us About MedTech07:36 Why Focus Beats Diversification08:55 Edwards Lifesciences' Strong Quarter10:14 Intuitive Surgical's Growth Engine11:01 Insulet’s 34% Growth Story12:52 Why Insulet’s Stock Fell Anyway23:39 Medtronic’s Return to Aggressive M&A24:53 J&J’s Cardiovascular Growth Strategy25:39 Abbott’s Cardiovascular Momentum26:12 Why Cardiovascular Is Dominating MedTech29:01 Key Takeaways From Q1 Earnings30:43 Boston Scientific’s $1.5B Structural Heart Bet31:48 Boston’s Third Attempt at TAVR37:47 J&J Acquires Atraverse Medical47:53 Is MedTech Entering an M&A Boom?49:40 Artivion Buys Endospan51:43 Medtronic Acquires SPR Therapeutics53:17 M&A Trends and Strategic Optionality55:38 Why More Acquisitions May Be Coming57:58 The Rise of Option-Based Deal Structures01:00:35 Speed Round: Notable Funding Deals01:01:00 Butterfly Medical $21M Series C01:02:27 SonoMind $23.5M Series A01:03:45 Aidoc Raises $150M01:05:30 Illuminant Surgical $8.4M Seed01:08:06 Perimeter Medical $10.5M Financing01:10:15 AI, Cancer Care, and Clinical Impact01:13:05 Biggest Lessons From May 202601:17:10 Final Thoughts on Focus, Growth, and M&A01:22:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #healthcareinnovation #medicaldevices #digitalhealth #medtechinnovation